Home›Search›Current Radiopharmaceuticals

Current Radiopharmaceuticals

Bentham Science Publishers · United Arab Emirates · Est. 1943

ISSN1874-4710eISSN1874-4729

SJR Q3✓ WOS SCIE✓ Scopus / SJR

/ 100

High Risk

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

✓ WoS SCIE/SSCI+25

✓ Scopus Q3+12

Total37

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Scorei

0.297

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.335

Total Worksi

666

Total Citationsi

7,875

2yr Mean Citednessi

1.67

Open Impact Factor alternative

Aims & Scope✦ Inferred from recent articles

This journal focuses on the development, application, and evaluation of radiopharmaceuticals and related imaging and therapeutic technologies, particularly in the context of cancer and other diseases. Articles cover molecular imaging, radionuclide therapy, dose calculation, and the integration of multi-omics and advanced imaging techniques for diagnosis and treatment.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Top 75% in field

General Information

Country / RegionUnited Arab Emirates

Primary LanguageEnglish

1st Year Published1943

Annual Volume~ 35 articles / year

StatusActive (last: 2026)

Total Publications666

Publisher OrgBentham Science Publishers

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Bentham Science Publishers

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1874-4710 / 1874-4729

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

664

2019

356

2020

191

2021

182

2022

191

2023

113

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

PharmacologyQ3

Radiology, Nuclear Medicine and ImagingQ3

Subject Classification

Web of Science Categories

Pharmacology & PharmacyRadiology, Nuclear Medicine & Medical Imaging

Scopus Categories

PharmacologyRadiology, Nuclear Medicine and Imaging

Frequently asked questions about Current Radiopharmaceuticals

Is Current Radiopharmaceuticals a predatory journal?

No major predatory indicators were found for Current Radiopharmaceuticals. It is indexed in Web of Science, Scopus and has a PubScope Trust Score of 37/100. Always confirm fit and policies before submitting.

What is the impact factor of Current Radiopharmaceuticals?

Current Radiopharmaceuticals is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (in the Journal Citation Reports). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.67.

Is Current Radiopharmaceuticals indexed in Scopus and Web of Science?

Current Radiopharmaceuticals is indexed in Web of Science, Scopus.